Research graph
References from Predictive Value of the Triglyceride–Glucose Index for Major Adverse Cardiovascular Events in Patients with Premature Coronary Artery Disease. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Premature coronary artery disease, risk factors, clinical presentation, angiography and interventions: Hospital based registry
10.1016/j.ihj.2022.08.003 · 2022 · External reference
Acute coronary syndromes in young patients: Phenotypes, causes and outcomes
10.1016/j.ijcard.2022.01.018 · 2022 · External reference
Risk Factors for Early-Onset Versus Late-Onset Coronary Heart Disease
10.1016/j.hlc.2023.07.010 · 2023 · External reference
Insulin resistance and cardiovascular disease
10.1210/jcem.86.8.7763 · 2001 · External reference
Role of insulin resistance in endothelial dysfunction
10.1007/s11154-012-9229-1 · 2013 · External reference
Type 2 diabetes mellitus
10.1038/nrdp.2015.19 · 2015 · External reference
The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects
2008 · External reference
Triglyceride-glucose index is associated with symptomatic coronary artery disease
10.1186/s12933-019-0893-2 · 2019 · External reference
Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients with premature coronary artery disease
10.1186/s12933-022-01576-8 · 2022 · External reference
Triglyceride-glucose index and coronary artery disease: A systematic review and meta-analysis of risk, severity, and prognosis
10.1186/s12933-023-01906-4 · 2023 · External reference
A more meaningful scoring system for determining the severity of coronary heart disease
10.1016/s0002-9149(83)80105-2 · 1983 · External reference
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension
10.1097/hjh.0000000000003480 · 2023 · External reference
Unresolved reference
External reference
2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
10.1093/eurheartj/ehz455 · 2020 · External reference
Optical Coherence Tomography of Plaque Erosion: JACC Focus Seminar Part 2/3
10.1016/j.jacc.2021.07.030 · 2021 · External reference
Optical coherence tomography in coronary atherosclerosis assessment and intervention
10.1038/s41569-022-00687-9 · 2022 · External reference
10.1186/s12872-025-05493-y
10.1186/s12872-025-05493-y · External reference
Lipid Variables Related to the Extent and Severity of Coronary Artery Disease in Non-Diabetic Turkish Cypriots
2015 · External reference
Clinical use of intracoronary imaging. Part 1: Guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
10.1093/eurheartj/ehy285 · 2018 · External reference
Role of insulin resistance in endothelial dysfunction
10.1007/s11154-012-9229-1 · ExternalCitation · doi-reference
Risk Factors for Early-Onset Versus Late-Onset Coronary Heart Disease
10.1016/j.hlc.2023.07.010 · ExternalCitation · doi-reference
Premature coronary artery disease, risk factors, clinical presentation, angiography and interventions: Hospital based registry
10.1016/j.ihj.2022.08.003 · ExternalCitation · doi-reference
Acute coronary syndromes in young patients: Phenotypes, causes and outcomes
10.1016/j.ijcard.2022.01.018 · ExternalCitation · doi-reference
Optical Coherence Tomography of Plaque Erosion: JACC Focus Seminar Part 2/3
10.1016/j.jacc.2021.07.030 · ExternalCitation · doi-reference
A more meaningful scoring system for determining the severity of coronary heart disease
10.1016/s0002-9149(83)80105-2 · ExternalCitation · doi-reference
Type 2 diabetes mellitus
10.1038/nrdp.2015.19 · ExternalCitation · doi-reference
Optical coherence tomography in coronary atherosclerosis assessment and intervention
10.1038/s41569-022-00687-9 · ExternalCitation · doi-reference
Clinical use of intracoronary imaging. Part 1: Guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
10.1093/eurheartj/ehy285 · ExternalCitation · doi-reference
2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
10.1093/eurheartj/ehz455 · ExternalCitation · doi-reference
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension
10.1097/hjh.0000000000003480 · ExternalCitation · doi-reference
10.1186/s12872-025-05493-y
10.1186/s12872-025-05493-y · ExternalCitation · doi-reference
Triglyceride-glucose index is associated with symptomatic coronary artery disease
10.1186/s12933-019-0893-2 · ExternalCitation · doi-reference
Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients with premature coronary artery disease
10.1186/s12933-022-01576-8 · ExternalCitation · doi-reference
Triglyceride-glucose index and coronary artery disease: A systematic review and meta-analysis of risk, severity, and prognosis
10.1186/s12933-023-01906-4 · ExternalCitation · doi-reference
Insulin resistance and cardiovascular disease
10.1210/jcem.86.8.7763 · ExternalCitation · doi-reference
